Back to Search
Start Over
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-7 AS A MARKER OF CARDIAC REVERSE REMODELING WITH EMPAGLIFLOZIN: A SECONDARY ANALYSIS OF THE EMPA-HEART CARDIOLINK-6 RANDOMIZED CONTROLLED TRIAL
- Source :
- Canadian Journal of Cardiology; October 2022, Vol. 38 Issue: 10, Number 10 Supplement 2 pS122-S122, 1p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 0828282X
- Volume :
- 38
- Issue :
- 10, Number 10 Supplement 2
- Database :
- Supplemental Index
- Journal :
- Canadian Journal of Cardiology
- Publication Type :
- Periodical
- Accession number :
- ejs61908145
- Full Text :
- https://doi.org/10.1016/j.cjca.2022.08.044